Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6209301

CSc1sc(C(=N)N)cc1S(=O)(=O)c1cccc(-c2ccc(NC(N)=NC(C)=O)cc2)c1C.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
C1S P09871 19/20 0.48
F2 P00734 1/20 0.44
F10 P00742 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6209552 0.91 C1S (0.50) C1SF2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL5841260 0.91 C1S (0.50) C1SF2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL6211999 0.90 C1S (0.46) C1SF2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL6209297 0.89 C1S (0.49) C1SF2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL6210224 0.87 C1S (0.43) C1SF2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL6208090 0.87 C1S (0.45) C1SF2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL6209814 0.87 C1S (0.47) C1SF2F10PRSS1PRSS2
Trifluoroacetic Acid SCHEMBL5840824 0.84 C1S (0.61) C1S
Trifluoroacetic Acid SCHEMBL5841092 0.77 C1S (0.75) C1S
Trifluoroacetic Acid SCHEMBL5842027 0.75 C1S (0.59) C1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549632-A4 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS DIMENSIONAL PHARM INC (US) 2005-11-09 EP disclosed
EP-1549632-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2005-07-06 EP disclosed
WO-2003099805-A1 NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-12-04 WO disclosed